Shares of Glenmark Pharmaceuticals surged 14% to an all-time high on Friday after its biotechnology unit, Ichnos Glenmark Innovation (IGI), signed a landmark licensing deal with US drugmaker AbbVie for its experimental blood cancer drug, ISB 2001. The agreement, announced late Thursday, marks one of the largest biotechnology licensing deals…
Levi Strauss & Co. shares surged more than 7% in premarket trading on Friday after the company raised its…
Braskem shares rallied on Wednesday after reports named the company as a key beneficiary of a proposed government incentive…
All eyes are on Nvidia Corp (NASDAQ: NVDA) this morning as the artificial intelligence giant continued to extend gains…
Linda Yaccarino has stepped down as CEO of X, the platform once known as Twitter, bringing an eventful chapter…
After imposing heavy tariffs on 14 nations and revealing plans to push import duties on the copper and pharma…
Apple Inc. is facing increased pressure from analysts to rethink its leadership strategy as it navigates a critical juncture…
Asia-Pacific stock markets began Thursday’s session with a mixed performance, as investors navigated a complex landscape of new US…
Shares of Core Scientific plunged after AI cloud provider CoreWeave announced plans to acquire the data center firm in…